about
MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.Factors secreted by endothelial progenitor cells enhance neurorepair responses after cerebral ischemia in miceUpdate on the Serum Biomarkers and Genetic Factors Associated with Safety and Efficacy of rt-PA Treatment in Acute Stroke Patients.Brain proteomics identifies potential simvastatin targets in acute phase of stroke in a rat embolic model.Rat middle cerebral artery occlusion is not a suitable model for the study of stroke-induced spontaneous infections.Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiSequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.Charge effect of a liposomal delivery system encapsulating simvastatin to treat experimental ischemic stroke in ratsCharacterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC).NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.Cerebral ischaemia and matrix metalloproteinase-9 modulate the angiogenic function of early and late outgrowth endothelial progenitor cells.Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.Mild hypothermia protects against oxygen glucose deprivation (OGD)-induced cell death in brain slices from adult mice.Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral β-amyloidosis.Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release.Matrix metalloproteinase-13 is activated and is found in the nucleus of neural cells after cerebral ischemia.Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage.Simvastatin blocks soluble SSAO/VAP-1 release in experimental models of cerebral ischemia: Possible benefits for stroke-induced inflammation control.Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease.Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke.Profiling and identification of new proteins involved in brain ischemia using MALDI-imaging-mass-spectrometry.Differentiating ischemic from hemorrhagic stroke using plasma biomarkers: the S100B/RAGE pathway.Plasma β-amyloid levels in cerebral amyloid angiopathy-associated hemorrhagic stroke.Modulation of Amyloid-β1-40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier.Combining statins with tissue plasminogen activator treatment after experimental and human stroke: a safety study on hemorrhagic transformation.MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.[The therapeutic potential of endothelial progenitor cells in ischaemic stroke]Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia.Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage.Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis.Identification of Plasma Biomarkers of Human Intracerebral Hemorrhage Subtypes through Microarray Technology.Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage.Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient dataACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathyPeripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 miceBrain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid AngiopathyCaspase-3 is related to infarct growth after human ischemic strokeLeukoaraiosis is associated with genes regulating blood-brain barrier homeostasis in ischaemic stroke patientsA large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke
P50
Q33322709-A5B75E3E-322F-4B55-BF3F-40C35654177AQ34984321-6ABE0875-2866-4060-8AE6-4E80599EC15FQ35109940-A384D1D1-EB09-4432-AB4D-1AA14F58AB5CQ35128709-CB1C7F2C-1B33-4741-A240-77D4866AFD13Q35186869-C471922A-20A0-44C7-9210-682C6AD4AF51Q35572825-541F615B-FCD0-4F92-A3C7-B373B4748A34Q35610552-15AF59CF-BEAB-4959-877F-BB4F159B37F6Q37070584-4A5702D1-7589-48F0-9FD8-A62F7E249DECQ38807780-A62BD4BD-063C-4472-B704-5E3E3C583ABDQ38928837-4A81B048-B0CB-4BD4-B5BB-3EF50CC8CDC8Q41916586-76B8E55D-F193-4054-B628-E2142C4CF338Q43031253-E9A386D5-9CCD-41D0-95DB-DCCE816F53EEQ44088934-0FA8C88C-14AD-4A7F-82AE-0F56D1EA18BFQ44355626-40FE1838-0640-4B0B-828A-ED1AD7495C9AQ44647403-8C8D10AC-5CFB-409C-BAA2-0C89755C2D95Q46264176-1E6A6EF2-F943-463A-A99B-987BB105BC63Q46421543-50EF9B07-AFF0-47EC-8297-7C453FD40B60Q47365568-AA61E905-F714-4F02-B1CF-7A52B05E4A28Q47754793-D03AD091-14D5-4A01-A5EB-FEE5F753EDB5Q48145219-60F0CB48-AB0A-4A27-87FA-7C113340E363Q48416684-B645C863-9984-444F-A946-23C9C0543C08Q48655678-2A12AFB2-BDE7-4998-9025-06A4DF659266Q48702297-BCFB24C4-66F4-400C-BEC7-481007E288DBQ48710938-42179748-B671-4D32-91ED-1D64CC6FBE6EQ48939391-6230548E-82AF-424E-B342-CC2E815CAA92Q49122434-AC8EDDCF-7724-4DB0-9746-795415096BEBQ49156452-978F9D61-4EB9-470D-AABE-D897C152858BQ50659008-D7360B9C-6E94-4A2C-9C88-1C72ED4C50A0Q51626299-EE22E117-E108-454A-9739-FD5BB9733FC4Q52147247-E5C097BC-308D-480C-AAD1-A885EE46722BQ52646154-68C494A7-B860-4900-B3A7-D821A49EEAADQ52985873-536E97A8-607D-48F3-BB10-E557B48B60B0Q53423639-066A5F78-7A64-4548-B472-171E7C8EE09AQ56888033-C0DCB260-AF5B-474D-B891-39F17FB6F178Q57495729-D90B5EA0-D8A3-4BF9-9A01-7409268D7391Q64057717-8EFB4DF6-A0AC-4C9B-87BE-AD569E002C6FQ64098004-B862FA0C-FA09-483D-BABB-06591F4C4886Q80136304-B8615A41-C80B-483F-A854-6BD09E822CA3Q82688027-6306B491-31CC-48D0-81EC-10588870F3DBQ83418836-30DAE9F5-6FAD-4FDD-B442-CCB87A66929C
P50
description
investigador
@es
researcher
@en
name
Mar Hernández-Guillamon
@en
Mar Hernández-Guillamon
@nl
type
label
Mar Hernández-Guillamon
@en
Mar Hernández-Guillamon
@nl
prefLabel
Mar Hernández-Guillamon
@en
Mar Hernández-Guillamon
@nl
P31
P496
0000-0001-8844-0091